Bo‐Mi Kim

1.4k total citations
62 papers, 1.1k citations indexed

About

Bo‐Mi Kim is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Bo‐Mi Kim has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Immunology and 16 papers in Oncology. Recurrent topics in Bo‐Mi Kim's work include Bone Metabolism and Diseases (16 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Renal Transplantation Outcomes and Treatments (8 papers). Bo‐Mi Kim is often cited by papers focused on Bone Metabolism and Diseases (16 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Renal Transplantation Outcomes and Treatments (8 papers). Bo‐Mi Kim collaborates with scholars based in South Korea, United States and United Kingdom. Bo‐Mi Kim's co-authors include Kyoung‐Woon Kim, Mi‐La Cho, Hae‐Rim Kim, Sang‐Heon Lee, Chul Woo Yang, Byung Ha Chung, Yong‐Soo Kim, Cheol Whee Park, Bum Soon Choi and Sang‐Heon Lee and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Bo‐Mi Kim

59 papers receiving 1.0k citations

Peers

Bo‐Mi Kim
Mitsuhiro Ueno Japan
Yuji Nozaki Japan
Saeed Daneshmandi Iran
Jasmina Markovic‐Lipkovski Serbia
Fengmei Wang China
Jae‐Hee Suh South Korea
Jianlin Chen China
Torsten Böhler Germany
Alfonso Oriente Italy
Mitsuhiro Ueno Japan
Bo‐Mi Kim
Citations per year, relative to Bo‐Mi Kim Bo‐Mi Kim (= 1×) peers Mitsuhiro Ueno

Countries citing papers authored by Bo‐Mi Kim

Since Specialization
Citations

This map shows the geographic impact of Bo‐Mi Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo‐Mi Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo‐Mi Kim more than expected).

Fields of papers citing papers by Bo‐Mi Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo‐Mi Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo‐Mi Kim. The network helps show where Bo‐Mi Kim may publish in the future.

Co-authorship network of co-authors of Bo‐Mi Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Bo‐Mi Kim. A scholar is included among the top collaborators of Bo‐Mi Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo‐Mi Kim. Bo‐Mi Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Bo‐Mi, Jungok Kim, Hae Suk Cheong, et al.. (2024). HLA-DPB1*05:01 and HLA-A*11:01 Is Associated with Adverse Drug Reactions to Isoniazid and Rifampin for Treatment of Latent Tuberculosis Infection in South Korea. Journal of Clinical Medicine. 13(12). 3563–3563. 2 indexed citations
2.
3.
Kim, Il‐Kwon, Bo‐Mi Kim, Byeong‐Wook Song, et al.. (2023). Borneol facilitates the whitening and anti-wrinkle effect of the essential oil extracted from Abies koreana needles. Journal of King Saud University - Science. 35(8). 102886–102886. 3 indexed citations
4.
Kim, Sang Chul, Eun‐Jeong Joo, Bo‐Mi Kim, et al.. (2022). Corticosteroid-induced drug reaction with eosinophilia and systematic symptoms successfully treated with a tumor necrosis factor alpha inhibitor. Asian Pacific Journal of Allergy and Immunology. 40(4). 418–421. 6 indexed citations
5.
Kim, Kyoung‐Woon, Yoo‐Jin Shin, Bo‐Mi Kim, et al.. (2021). Modeling of endothelial cell dysfunction using human induced pluripotent stem cells derived from patients with end-stage renal disease. Kidney Research and Clinical Practice. 40(4). 698–711. 8 indexed citations
6.
7.
Min, Ji Won, Yoo‐Jin Shin, Hyeyoung Lee, et al.. (2021). BAFF Inhibition Effectively Suppresses the Development of Anti-HLA.A2 Antibody in the Highly Sensitized Mouse Model. International Journal of Molecular Sciences. 22(2). 861–861. 2 indexed citations
8.
Kim, Bo‐Mi, et al.. (2019). Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression. BMC Complementary and Alternative Medicine. 19(1). 54–54. 15 indexed citations
9.
Kim, Kyoung‐Woon, et al.. (2019). Intravenous Immunoglobulin Controls Th17 Cell-Mediated Osteoclastogenesis. Immune Network. 19(4). e27–e27. 4 indexed citations
10.
Lee, Kyung‐Ann, Kyoung‐Woon Kim, Bo‐Mi Kim, et al.. (2019). Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis. Arthritis Research & Therapy. 21(1). 283–283. 15 indexed citations
11.
Lee, Yu Ho, Jung-Woo Seo, Yang‐Gyun Kim, et al.. (2018). Validation Study of an Operational Tolerance Signature in Korean Kidney Transplant Recipients. Immune Network. 18(5). 4 indexed citations
12.
Kim, Kyoung‐Woon, Bo‐Mi Kim, Chan‐Duck Kim, et al.. (2018). Clinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients. PLoS ONE. 13(7). e0200631–e0200631. 6 indexed citations
13.
Lee, Kyung‐Ann, Kyoung‐Woon Kim, Bo‐Mi Kim, et al.. (2018). Clinical and diagnostic significance of serum immunoglobulin A rheumatoid factor in primary Sjogren’s syndrome. Clinical Oral Investigations. 23(3). 1415–1423. 13 indexed citations
14.
Kim, Hae‐Rim, Bo‐Mi Kim, Hyun Myung Ko, et al.. (2018). Quercetin, a Plant Polyphenol, Has Potential for the Prevention of Bone Destruction in Rheumatoid Arthritis. Journal of Medicinal Food. 22(2). 152–161. 60 indexed citations
15.
Chung, Byung Ha, et al.. (2017). Protective effect of 1α,25-dihydroxyvitamin D3 on effector CD4+ T cell induced injury in human renal proximal tubular epithelial cells. PLoS ONE. 12(2). e0172536–e0172536. 13 indexed citations
16.
Kim, Kyoung‐Woon, et al.. (2017). Histamine and Histamine H4 Receptor Promotes Osteoclastogenesis in Rheumatoid Arthritis. Scientific Reports. 7(1). 1197–1197. 25 indexed citations
17.
Kim, Hae‐Rim, et al.. (2017). N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL in rheumatoid arthritis. The Korean Journal of Internal Medicine. 34(1). 210–219. 29 indexed citations
18.
Kang, Kyeongah, Sorim Nam, Bo‐Mi Kim, et al.. (2015). Inhibition of osteoclast differentiation by overexpression of NDRG2 in monocytes. Biochemical and Biophysical Research Communications. 468(4). 611–616. 13 indexed citations
19.
Chung, Byung Ha, et al.. (2015). Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction. PLoS ONE. 10(12). e0145258–e0145258. 40 indexed citations
20.
Kim, Hae‐Rim, Kyoung‐Woon Kim, Bo‐Mi Kim, Mi‐La Cho, & Sang‐Heon Lee. (2015). The Effect of Vascular Endothelial Growth Factor on Osteoclastogenesis in Rheumatoid Arthritis. PLoS ONE. 10(4). e0124909–e0124909. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuhiro Ueno Breakdown of academic impact, for papers by Yuji Nozaki Breakdown of academic impact, for papers by Saeed Daneshmandi Breakdown of academic impact, for papers by Jasmina Markovic‐Lipkovski Breakdown of academic impact, for papers by Fengmei Wang Breakdown of academic impact, for papers by Jae‐Hee Suh Breakdown of academic impact, for papers by Jianlin Chen Breakdown of academic impact, for papers by Torsten Böhler Breakdown of academic impact, for papers by Alfonso Oriente
Rankless by CCL
2026